Elevance Health Inc. (ELV)

Elevance Health topped expectations on both the top and bottom line in the second fiscal quarter of 2026, reported July 15, as adjusted EPS of $7.45 beat the $6.21 estimate by 20.0% and revenue of about $50.5 billion topped the $48.9 billion consensus by 1.9%. Revenue rose 1.4% from about $49.8 billion a year earlier, with gross margin near 89.1% and operating margin around 4.1%, while net income fell 16.1% to roughly $1.5 billion from about $1.7 billion a year earlier. The company generated operating cash flow of about $1.9 billion, repurchased about $234 million of stock and paid about $373 million in dividends. Consensus for the next period calls for EPS of $4.79 on revenue of $49.26 billion.